Advertisement

Payer

Proposed legislation making its way through Congress that would cap the out-of-pocket cost for insulin at $35 would do nothing to lower the price of insulin, according to health insurer lobby and trade group America's Health Insurance Plans. 

Advertisement
Advertisement